NCT04633746View on ClinicalTrials.gov

Plasma Endostatin Predicts Outcome of Septic AKI

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

January 20, 2019

Primary Completion Date

June 30, 2020

Study Completion Date

August 31, 2020

Conditions
Acute Kidney Injury Due to Sepsis
Interventions
DIAGNOSTIC_TEST

measuring plasma Endostatin level

measuring plasma Endostatin level at the time of admission then after 48hrs and 96 hours

Trial Locations (1)

11345

Farouk Faris, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT04633746 - Plasma Endostatin Predicts Outcome of Septic AKI | Biotech Hunter | Biotech Hunter